Table 2.

Clinical and demographic data

ParameterAnuric (n=12)Nonanuric (n=12)Total (n=24)
Males6 (50%)6 (50%)12 (50%)
Age (years)75 (64–82)52 (37–68)68 (46–78)
Weight (kg)79.0 (70.3–88.0)77.5 (65.5–88.0)78.0 (68.8–88.0)
Intraperitoneal gentamicin dose (mg)47.5 (41.0–55.0)47.5 (40.0–52.0)47.5 (40.0–52.0)
Intraperitoneal gentamicin dose (mg/kg)0.60 (0.59–0.60)0.60 (0.57–0.62)0.60 (0.58–0.61)
Urine output (ml/24 h)0 (0–42)533 (177–827)173 (19–625)
Peritoneal membrane type
 low average3 (25%)3 (25%)6 (25%)
 high average5 (42%)6 (50%)11 (46%)
 high4 (33%)3 (25%)7 (29%)
Duration of intraperitoneal gentamicin therapy (days)3.5 (2–11)14 (4.5–21)5 (3–21)
  • All values are reported as n (%) or median (interquartile range).